Amit Chopra

CEO (South Asia, & Middle East)

The global landscape of the pharmaceutical research and testing market is expanding rapidly. On one hand, regions like Western Europe maintain their promi­nence in this domain due to the existence of flourishing phar­maceutical hubs like Switzerland, Germany, and the UK. On the other hand, regions like Eastern Europe and India are quickly gaining momentum, benefiting from cost advantages and growing investments in research infrastructure. Simul­taneously, the Indian market is expanding, driven by factors like higher demand for quality assurance in pharmaceuticals, tightening regulatory frameworks, rise of biotechnology and personalized medicine, and governmental interest in boost­ing the healthcare sector.

Nevertheless, the industry is not without its challenges. Clients often face issues like delays in product delivery, compliance with international regulations, and maintaining quality standards throughout their supply chains. To address these challenges, leveraging industry developments through innovative solutions and expertise, Geneva-based Cotecna offers complete pharma inspection and testing services. Cotecna services align and comply with relevant regulatory requirements and improve supply chain transparency.

Comprehensive Testing and Certification Services

Cotecna uses advanced technologies to facilitate the real-time monitoring of supply chain processes. As a result, the firm enables clients to identify disruptions early in the development process, providing solutions to mitigate risks effectively. Moreover, the synergy between Neotron, Shiva Analyticals and other Cotecna Group laboratories allows the company to offer end-to-end quality control solutions through services like material testing, product inspections, and pre-shipment verification. In addition to pharmaceuticals, Cotecna also serves clients in diverse industries including agriculture, food, metals & minerals, consumer products and various certification like ESG and verification of conformity. To stay ahead, Cotecna continually invests in technology and innovation. These solutions are suitable for the firm’s Indian clients looking to enter markets in Europe, Asia and other regions.

“Our commitment to research and development allows us to stay ahead of industry trends and meet evolving client needs. By fostering a culture of continuous improvement and agility, we ensure that our services remain relevant and effective in a rapidly changing environment. We differentiate ourselves through our commitment to quality, a customer-centric approach, and an extensive global network. Our tailored solutions address specific client needs, ensuring that we provide not just services but strategic partnerships that drive success. We emphasize transparency and communication throughout the testing process, which builds trust and fosters long-term relationships with our clients”, shares Amit CEO (India, South Asia & Middle East), Cotecna.

A key advantage of Cotecna’s solutions is their compliance with international regulatory standards. This helps the company carry out operations requiring diverse compliance across multiple global regulatory environments. The Cotecna team utilizes a vigorous quality management system that adheres to the ISO as well as GMP standards, ensuring precision in its inspection and testing services. Moreover, the firm is strengthened by its teams of seasoned professionals that are exclusively trained to navigate the complexities of local regulations with ease while providing solutions that align with global best practices. The team also conducts regular audits and internal assessments, making sure that the company only executes services and operations that meet with the highest standards of quality and safety.

Apart from the comprehensive services it offers, Cotecna is also greatly invested in promoting sustainability. As such, it undertakes several measures such as implementing environmentally friendly practices in its operations like reducing waste through efficient resource management and utilizing sustainable materials wherever possible. The company also engages with its stakeholders extensively, promoting ethical practices across its supply chains and ensuring compliance with the international labor standards as well as environmental regulations.

To prioritize customer satisfaction, Cotecna keeps a close eye on the effectiveness and success of its services, closely monitoring them through a number of KPIs like turnaround time for testing services, client retention rates, compliance rates with regulatory standards, and customer feedback scores. Leveraging data collected from these sources, the firm identifies areas of improvement, continually upgrading its solutions and services to align with client expectations.

Future Roadmap

With a legacy of excellence in the domain, spanning over 50 years, Cotecna has carved a distinctive position and reputation in the global Testing, Inspection & Certification (TIC) market for itself. Dedicated to delivering services and solutions that surpass expectations, Cotecna takes great pride in its integrity, which remains a cornerstone of its future vision for growth.

“I would like to emphasize Cotecna's commitment to excellence in service delivery. We are dedicated to maintaining high standards of quality while continuously seeking ways to innovate and improve our offerings for the benefit of our clients and the healthcare industry at large”, adds Amit Chopra. Aligned with this aspiration, Cotecna has planned a robust roadmap that focuses on expansion of service offerings in microbiology testing. For this, the firm aims to integrate cutting-edge technologies such as artificial intelligence and machine learning across processes and explore the BioPharmaceutical testing vertical. Building further, the company also plans to boost its global footprint by forging strategic partnerships in growing markets, while simultaneously investing significantly in employee training and development to foster innovation. Through these diverse and multifaceted strategies, Cotecna not only aims to expand the scope of its solutions that will lead to greater visibility across geographies, but it also plans to become one of the leading authority in the pharmaceuticals testing industry globally.